Bridgewest Ventures
Bridgewest Ventures is an incubator firm based in Auckland, New Zealand. The firm seeks to invest in companies operating in the biotechnology, agtech, pharmaceuticals, unmanned aerial vehicles technology, internet of things, semiconductor, artificial intelligence, software development, drug discovery, life sciences, and health tech sectors across New Zealand.
TheiaNova provides nonsurgical therapies to patients with vision impairment due to ecstatic vision disorders. A patient suffering from keratoconus will undergo therapeutic remodeling of the cornea with the company's therapy, allowing healthcare professionals to focus on correcting vision impairments with glasses and corrective lenses or halting progression of the disease with corneal crosslinking.
MACSO aims to give AI the capacity to mimic human senses in order to prevent catastrophes from occurring. Their initial application employs AI and acoustic sensors to identify respiratory sickness in animals on commercial livestock farms early. MACSO is headquartered in Auckland, New Zealand and was founded in 2021.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.